Regarding Nails notes, the article he sights of a recent HIV study was supported by Gilead for the donation of the drugs, while Merck is a financial backer of some of the institutes involed. It was a fairly large study in South Africa comparing outcomes of the the ART therapies, the same drugs used in our own trial.
I think it is almost a given that if any BP back BIT225, it will be Gilead.
Regarding Nails notes, the article he sights of a recent HIV...
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.2¢ |
Change
-0.002(3.70%) |
Mkt cap ! $48.72M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.6¢ | 5.2¢ | $25.88K | 491.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6400 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 174339 | 2 |
View Market Depth
| Last trade - 12.36pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
5.2¢ |
Change
-0.002 ( 3.70 %) |
||||
| Open | High | Low | Volume | ||
| 5.2¢ | 5.2¢ | 5.2¢ | 45911 | ||
| Last updated 12.36pm 06/05/2024 ? | |||||
| BIT (ASX) Chart |